Latest Paul S. Mischel Stories
Tumor cells temporarily lose mutation to evade drugs targeting mutation A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped. The...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.